Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Jun;70(824):411–417. doi: 10.1136/pgmj.70.824.411

Thrombophilia: how far should a clotter be investigated?

I D Walker 1
PMCID: PMC2397709  PMID: 8029160

Full text

PDF
411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer K. A. Hypercoagulability--a new cofactor in the protein C anticoagulant pathway. N Engl J Med. 1994 Feb 24;330(8):566–567. doi: 10.1056/NEJM199402243300810. [DOI] [PubMed] [Google Scholar]
  2. Bauer K. A., Rosenberg R. D. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood. 1987 Aug;70(2):343–350. [PubMed] [Google Scholar]
  3. Bauer K. A., Rosenberg R. D. Thrombin generation in acute promyelocytic leukemia. Blood. 1984 Oct;64(4):791–796. [PubMed] [Google Scholar]
  4. Bevers E. M., Galli M., Barbui T., Comfurius P., Zwaal R. F. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost. 1991 Dec 2;66(6):629–632. [PubMed] [Google Scholar]
  5. Bithell T. C. Hereditary dysfibrinogenemia. Clin Chem. 1985 Apr;31(4):509–516. [PubMed] [Google Scholar]
  6. Bovill E. G., Tomczak J. A., Grant B., Bhushan F., Pillemer E., Rainville I. R., Long G. L. Protein CVermont: symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood. 1992 Mar 15;79(6):1456–1465. [PubMed] [Google Scholar]
  7. Broekmans A. W., Veltkamp J. J., Bertina R. M. Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. N Engl J Med. 1983 Aug 11;309(6):340–344. doi: 10.1056/NEJM198308113090604. [DOI] [PubMed] [Google Scholar]
  8. Comp P. C., Nixon R. R., Cooper M. R., Esmon C. T. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984 Dec;74(6):2082–2088. doi: 10.1172/JCI111632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cooper D. N. The molecular genetics of familial venous thrombosis. Blood Rev. 1991 Mar;5(1):55–70. doi: 10.1016/0268-960x(91)90009-2. [DOI] [PubMed] [Google Scholar]
  10. Dahlbäck B., Carlsson M., Svensson P. J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004–1008. doi: 10.1073/pnas.90.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. EGEBERG O. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh. 1965 Jun 15;13:516–530. [PubMed] [Google Scholar]
  12. Elias M., Eldor A. Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. Arch Intern Med. 1984 Mar;144(3):510–515. [PubMed] [Google Scholar]
  13. Engesser L., Broekmans A. W., Briët E., Brommer E. J., Bertina R. M. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med. 1987 May;106(5):677–682. doi: 10.7326/0003-4819-106-5-677. [DOI] [PubMed] [Google Scholar]
  14. Finazzi G., Caccia R., Barbui T. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases. Thromb Haemost. 1987 Dec 18;58(4):1094–1094. [PubMed] [Google Scholar]
  15. Gladson C. L., Scharrer I., Hach V., Beck K. H., Griffin J. H. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost. 1988 Feb 25;59(1):18–22. [PubMed] [Google Scholar]
  16. Griffin J. H., Evatt B., Wideman C., Fernández J. A. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood. 1993 Oct 1;82(7):1989–1993. [PubMed] [Google Scholar]
  17. Hach-Wunderle V., Scharrer I., Lottenberg R. Congenital deficiency of plasminogen and its relationship to venous thrombosis. Thromb Haemost. 1988 Apr 8;59(2):277–280. [PubMed] [Google Scholar]
  18. Harris E. N., Gharavi A. E., Boey M. L., Patel B. M., Mackworth-Young C. G., Loizou S., Hughes G. R. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983 Nov 26;2(8361):1211–1214. doi: 10.1016/s0140-6736(83)91267-9. [DOI] [PubMed] [Google Scholar]
  19. Hughes G. R. The antiphospholipid syndrome: ten years on. Lancet. 1993 Aug 7;342(8867):341–344. doi: 10.1016/0140-6736(93)91477-4. [DOI] [PubMed] [Google Scholar]
  20. Hultin M. B., McKay J., Abildgaard U. Antithrombin Oslo: type Ib classification of the first reported antithrombin-deficient family, with a review of hereditary antithrombin variants. Thromb Haemost. 1988 Jun 16;59(3):468–473. [PubMed] [Google Scholar]
  21. Juhan-Vague I., Valadier J., Alessi M. C., Aillaud M. F., Ansaldi J., Philip-Joet C., Holvoet P., Serradimigni A., Collen D. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost. 1987 Feb 3;57(1):67–72. [PubMed] [Google Scholar]
  22. Koster T., Rosendaal F. R., de Ronde H., Briët E., Vandenbroucke J. P., Bertina R. M. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993 Dec 18;342(8886-8887):1503–1506. doi: 10.1016/s0140-6736(05)80081-9. [DOI] [PubMed] [Google Scholar]
  23. Lane D. A., Ireland H., Olds R. J., Thein S. L., Perry D. J., Aiach M. Antithrombin III: a database of mutations. Thromb Haemost. 1991 Dec 2;66(6):657–661. [PubMed] [Google Scholar]
  24. Lane D. A., Olds R. J., Boisclair M., Chowdhury V., Thein S. L., Cooper D. N., Blajchman M., Perry D., Emmerich J., Aiach M. Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 1993 Aug 2;70(2):361–369. [PubMed] [Google Scholar]
  25. Lechner K., Pabinger-Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis. 1985;15(4):254–262. doi: 10.1159/000215157. [DOI] [PubMed] [Google Scholar]
  26. Long A. A., Ginsberg J. S., Brill-Edwards P., Johnston M., Turner C., Denburg J. A., Bensen W. G., Cividino A., Andrew M., Hirsh J. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost. 1991 Nov 1;66(5):520–524. [PubMed] [Google Scholar]
  27. Love P. E., Santoro S. A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990 May 1;112(9):682–698. doi: 10.7326/0003-4819-112-9-682. [DOI] [PubMed] [Google Scholar]
  28. Malm J., Laurell M., Nilsson I. M., Dahlbäck B. Thromboembolic disease--critical evaluation of laboratory investigation. Thromb Haemost. 1992 Jul 6;68(1):7–13. [PubMed] [Google Scholar]
  29. Mannucci P. M., Tripodi A., Bottasso B., Baudo F., Finazzi G., De Stefano V., Palareti G., Manotti C., Mazzucconi M. G., Castaman G. Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thromb Haemost. 1992 Feb 3;67(2):200–202. [PubMed] [Google Scholar]
  30. Marciniak E., Wilson H. D., Marlar R. A. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood. 1985 Jan;65(1):15–20. [PubMed] [Google Scholar]
  31. McNeil H. P., Simpson R. J., Chesterman C. N., Krilis S. A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990 Jun;87(11):4120–4124. doi: 10.1073/pnas.87.11.4120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Melissari E., Monte G., Lindo V. S., Pemberton K. D., Wilson N. V., Edmondson R., Das S., Kakkar V. V. Congenital thrombophilia among patients with venous thromboembolism. Blood Coagul Fibrinolysis. 1992 Dec;3(6):749–758. doi: 10.1097/00001721-199212000-00008. [DOI] [PubMed] [Google Scholar]
  33. Miletich J. P., Prescott S. M., White R., Majerus P. W., Bovill E. G. Inherited predisposition to thrombosis. Cell. 1993 Feb 26;72(4):477–480. doi: 10.1016/0092-8674(93)90063-v. [DOI] [PubMed] [Google Scholar]
  34. Miletich J., Sherman L., Broze G., Jr Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med. 1987 Oct 15;317(16):991–996. doi: 10.1056/NEJM198710153171604. [DOI] [PubMed] [Google Scholar]
  35. Molho-Sabatier P., Aiach M., Gaillard I., Fiessinger J. N., Fischer A. M., Chadeuf G., Clauser E. Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation. J Clin Invest. 1989 Oct;84(4):1236–1242. doi: 10.1172/JCI114290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nossel H. L., Yudelman I., Canfield R. E., Butler V. P., Jr, Spanondis K., Wilner G. D., Qureshi G. D. Measurement of fibrinopeptide A in human blood. J Clin Invest. 1974 Jul;54(1):43–53. doi: 10.1172/JCI107749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Owen J. The utility of plasma fibrinopeptide assays. Thromb Haemost. 1989 Sep 29;62(2):807–810. [PubMed] [Google Scholar]
  38. Pabinger I., Brücker S., Kyrle P. A., Schneider B., Korninger H. C., Niessner H., Lechner K. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagul Fibrinolysis. 1992 Oct;3(5):547–553. [PubMed] [Google Scholar]
  39. Reitsma P. H., Poort S. R., Bernardi F., Gandrille S., Long G. L., Sala N., Cooper D. N. Protein C deficiency: a database of mutations. For the Protein C & S Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 1993 Jan 11;69(1):77–84. [PubMed] [Google Scholar]
  40. Scharrer I. M., Wohl R. C., Hach V., Sinio L., Boreisha I., Robbins K. C. Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis. Thromb Haemost. 1986 Jun 30;55(3):396–401. [PubMed] [Google Scholar]
  41. Schwarz H. P., Fischer M., Hopmeier P., Batard M. A., Griffin J. H. Plasma protein S deficiency in familial thrombotic disease. Blood. 1984 Dec;64(6):1297–1300. [PubMed] [Google Scholar]
  42. Seligsohn U., Berger A., Abend M., Rubin L., Attias D., Zivelin A., Rapaport S. I. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med. 1984 Mar 1;310(9):559–562. doi: 10.1056/NEJM198403013100904. [DOI] [PubMed] [Google Scholar]
  43. Tait R. C., Walker I. D., Islam S. I., McCall F., Conkie J. A., Wight M., Mitchell R., Davidson J. F. Protein C activity in healthy volunteers--influence of age, sex, smoking and oral contraceptives. Thromb Haemost. 1993 Aug 2;70(2):281–285. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES